MUVON Therapeutics ^Company

MUVON Therapeutics is a biotech startup based in Zurich, founded in 2020, with a focus in developing minimally invasive personalized cell therapies for the regeneration of skeletal muscle tissue. Our initial aim is the treatment of stress urinary incontinence in women (an estimated 30-60% of women over the age of 40 years are affected, impacting their physical and psychological health) to help them regain control and improve their quality of life.